Author

Purohit Sharad Prahaldbhai

Observed names: P.S. Prahaldbhai, Prahaldbhai, Purohit Sharad, Purohit Prahaldbhai, Purohit S. Prahaldbhai

Institution: Sanjivani Super Speciality Hospitals

Observed institutions: Rush University Medical Center, Sanjivani Super Speciality Hospitals, St.John's Medical College Hospital, Post Graduate Institute of Medical Education and Research

ORCID: 0009-0002-2066-7729

Observed ORCID: 0009-0002-2066-7729

OpenAlex ID: A5085385042

Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study

2023 · Pawan Kumar Gupta, Sunil Maheshwari, et al. · The American Journal of Sports Medicine · 55

Two years efficacy and safety outcomes of using allogeneic, pooled mesenchymal stromal cells for osteoarthritis of knee in a double-blind randomized placebo-controlled phase 3 study

2025 · Pawan Kumar Gupta, Sunil Maheshwari, et al. · Osteoarthritis and Cartilage Open · 5

Poster 268: Allogeneic, Off The Shelf, Bone Marrow derived, Pooled, Mesenchymal Stromal Cells – A Potential Break through Therapy for Grade II & III Osteoarthritis Knee Management

2022 · Sunil Maheswari, Joe Cherian, et al. · Orthopaedic Journal of Sports Medicine · 2

Allogeneic, Off the Shelf, Pooled, Bone Marrow Derived Mesenchymal Stromal Cells (stempeucel®) – Results: From Pivotal Trials of a Commercially Approved Therapy in India for Grade Ii & Iii Osteoarthritis Knee

2025 · Pawan K. Gupta, Sunil Maheshwari, et al. · Osteoarthritis and Cartilage · 1

Mesenchymal Stem/Stromal Cells: ALLOGENEIC, OFF THE SHELF, POOLED, BM - MSCS (STEMPEUCEL®) – A POTENTIAL BREAK THROUGH THERAPY FOR GRADE II AND III OSTEOARTHRITIS KNEE

2022 · P.K. Gupta, S. Maheshwari, et al. · Cytotherapy · 1

Works count: 7

Citation count: 64

H-index: 2

I10-index: 1